| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |